Protembis
Aachen
Germany
About Protembis
Founded in 2013, Protembis is a medical device start-up company with its R&D base in the engineering and technology city of Aachen, Germany.YEAR FOUNDED:
2013
8 articles about Protembis
-
Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial
4/2/2024
Protembis GmbH, a privately-held emerging cardiovascular medical device company, announced the enrollment of the first patient in the PROTEMBO Investigational Device Exemption Pivotal Trial.
-
Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors
3/26/2024
Protembis GmbH announced the completion of a € 30 million Series B financing round to support the enrollment of the PROTEMBO Investigational Device Exemption Pivotal Trial.
-
Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study
10/19/2023
Protembis GmbH a privately-held emerging cardiovascular medical device company, announced the FDA has approved the PROTEMBO Pivotal IDE Trial.
-
Professor J Mocco to Join Protembis’ Board of Directors
8/29/2023
Protembis GmbH announced the appointment of Professor J Mocco MD, MS, FAANS, FAHA of Icahn School of Medicine at Mount Sinai, NY, USA as an independent member of their Board of Directors.
-
Azin Parhizgar To Chair Protembis’ New Board of Directors
9/15/2022
Protembis GmbH announced the appointment of highly experienced and successful serial entrepreneur and medical device executive Azin Parhizgar as an Independent Member and Chairwoman of the Board of Directors.
-
Protembis Announces Completion of 20 Cases in European CE Mark Study With the ProtEmbo® Cerebral Protection System
2/25/2021
Enrollment with advanced generation device for complete cerebral protection nearing halfway mark in clinical study in Germany and Poland
-
Aachen-based Startup Company Protembis Successfully Closes $ 10 Million Series A Financing
10/26/2018
The Managing Directors and founders of Protembis GmbH, Karl von Mangoldt and Conrad Rasmus, have successfully closed a Series A financing round in a structured process.
-
Protembis Announces Successful First-In-Human Use Of Its Protembo Cerebral Protection System In European Trial
9/5/2017